Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403091 | 12540309 | 1 | I | 20160622 | 20160705 | 20160708 | 20160708 | EXP | GB-ASTRAZENECA-2016SE73202 | ASTRAZENECA | 67.00 | YR | M | Y | 0.00000 | 20160708 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125403091 | 12540309 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 19810 | ||||||||||
| 125403091 | 12540309 | 2 | SS | RAMIPRIL. | RAMIPRIL | 1 | Oral | U | 0 | ||||||||||
| 125403091 | 12540309 | 3 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 125403091 | 12540309 | 4 | SS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 125403091 | 12540309 | 5 | SS | EZETIMIBE. | EZETIMIBE | 1 | Oral | U | 0 | TABLET | |||||||||
| 125403091 | 12540309 | 6 | SS | INSULIN | INSULIN NOS | 1 | Unknown | U | 0 | ||||||||||
| 125403091 | 12540309 | 7 | SS | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125403091 | 12540309 | HO |
| 125403091 | 12540309 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125403091 | 12540309 | Acute kidney injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |